本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Madrigal Pharmaceuticals, Inc.

517.86
-22.2050-4.11%
成交量:15.70萬
成交額:8,156.75萬
市值:119.39億
市盈率:-36.43
高:539.71
開:539.25
低:513.36
收:540.06
52周最高:615.00
52周最低:393.61
股本:2,305.55萬
流通股本:1,372.50萬
量比:0.86
換手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-14.2164
每股收益(LYR):-12.8501
淨資產收益率:-53.31%
總資產收益率:-17.84%
市淨率:22.80
市盈率(LYR):-40.30

資料載入中...

2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/19

重要事件披露

Form 8-K - Current report
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/11

重要事件披露

Form 8-K - Current report
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities